Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Ipamorelin and Vesugen Interaction: Synergistic | Peptide Database

Compound Profiles Ipamorelin Growth Hormone Secretagogue | Selective GHRP Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cor

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Ipamorelin

Growth Hormone Secretagogue | Selective GHRP

Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..

Vesugen

KED | Vascular Bioregulator Peptide

Vesugen works through epigenetic regulation by interacting with DNA promoter regions, particularly affecting Ki-67 gene expression which controls cell division. It plays a prominent role in regulating sirtuin 1 (SIRT1) protein levels - a key anti-aging protein activated during calorie restriction.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Ipamorelin with Vesugen?

Yes, Ipamorelin and Vesugen can generally be taken together. Ipamorelin and Vesugen work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is Ipamorelin and Vesugen safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Ipamorelin and Vesugen?

Ipamorelin and Vesugen work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Ipamorelin and Vesugen?

Ipamorelin has a half-life of ~2 hours and Vesugen has a half-life of Not established. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Stimulates thymocyte proliferation and enlarges thymic lobules. Activates T-helper cells and improves immune response. Restores chromatin structure and gene expression in aged lymphocytes. Long-term treatment increased mean lifespan 20-40% in rodent studies. Suppresses development of spontaneous and induced tumors. Promotes recovery in tissues exposed to radiation damage. Restores brush border membrane enzyme levels in aged animals. Enhances intestinal barrier function in aged rats.

Source: peptide-db.com ↗

Research Indications

FDA-approved indication. Stanozolol increases plasma levels of C1-esterase inhibitor and C4 complement, reducing the frequency and severity of angioedema episodes characterized by localized swelling of the skin, mucous membranes, and internal organs. Previously used to stimulate erythropoiesis in patients with aplastic anemia and other bone marrow failure states. Largely replaced by erythropoietin-stimulating agents and other modern therapies, though it demonstrated efficacy in stimulating red blood cell production. Widely used during caloric deficit phases to preserve lean mass and enhance muscle hardness, vascularity, and definition. The absence of water retention produces a dry, striated appearance that is highly valued in competitive bodybuilding. Provides significant increases in maximal and explosive strength without substantial body weight gain. Historically popular in weight-class-restricted sports, track and field, and combat sports for this reason. Enhances speed and power output through improved neuromuscular efficiency, increased red blood cell count, and enhanced protein synthesis. The lack of water weight gain is advantageous for athletes where power-to-weight ratio is critical. Anti-catabolic properties help preserve lean tissue during aggressive caloric restriction. The potent SHBG suppression enhances free testosterone levels, further supporting muscle preservation.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Tamoxifen is administered orally as a tablet, typically tamoxifen citrate. It is well absorbed from the gastrointestinal tract with peak plasma levels reached within 4-7 hours. The extremely long half-life of 5-7 days means steady-state concentrations are achieved after approximately 4 weeks of daily dosing. Can be taken with or without food. Due to the long half-life, missed doses have minimal impact on therapeutic levels. Post-cycle therapy (standard tapered protocol) 40mg daily for 2 weeks, then 20mg daily for 2 weeks Once daily for 4 weeks total Oral Post-cycle therapy (moderate) 20mg Once daily for 4-6 weeks Post-cycle therapy (extended, heavy suppression) 40mg daily for 2 weeks, then 20mg daily for 4 weeks Once daily for 6 weeks total On-cycle gynecomastia prevention 10-20mg Once daily throughout cycle Breast cancer treatment (medical) Once daily for 5-10 years

Source: peptide-db.com ↗
Side effects

Common Side Effects

Decreased libido (reported in 3-5% of men; somewhat higher incidence than finasteride due to greater DHT suppression) Erectile dysfunction (reported in 3-5%; more frequently reported than with finasteride) Decreased ejaculate volume (reported in 1-2%) Gynecomastia or breast tenderness (reported in approximately 1-2%)

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides